Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human fecal samples of MAFLD patients and Healthy people

ABSTRACT: Human fecal samples of MAFLD patients and Healthy people Raw sequence reads

PROVIDER: PRJNA930148 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23298600_1.fastq.gz	Fastqsanger.gz
	SRR23298600_2.fastq.gz	Fastqsanger.gz
	SRR23298700_1.fastq.gz	Fastqsanger.gz
	SRR23298700_2.fastq.gz	Fastqsanger.gz
	SRR23298601_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 538

Similar Datasets

Fecal fermentation liquid for healthy people

Project description:Fecal fermentation liquid for healthy people Raw sequence reads

| PRJNA982619 | ENA

Fecal samples from healthy Chinese people and patients with aortic dissection measured by metagenomics

Project description:Fecal samples from healthy Chinese people and patients with aortic dissection measured by metagenomics Raw sequence reads

| PRJNA1102998 | ENA

Differences in gene expression of liver tissues between MAFLD patients and controls.

Project description:Transcriptomic analysis was applied to liver tissues of seven patients with MAFLD and nine normal controls,then, differential genes were identified by comparative analysis of sequencing results, and target genes that may be related to the pathogenesis of MAFLD were further studied.This study may provide new ideas for understanding the pathogenesis of MAFLD and thus provide new targets for the treatment of MAFLD.

2021-12-14 | GSE183229 | GEO

Exploring differentially expressed miRNAs (DEmiRNAs) in plasma sample between lung adenocarcinoma patients and healthy people

Project description:Exploring differentially expressed miRNAs (DEmiRNAs) in plasma sample between lung adenocarcinoma patients and healthy people using a small RNA (sRNA) sequencing,results showed that we could used these DEmiRNAs identified could discriminate healthy peoples from lung adenocarcinoma patients. In present study, we applied an RNA sequencing (RNA-seq) approach to explore the differentially expressed miRNAs (DEmiRNAs) in plasma sample between 6 lung adenocarcinoma patients and 4 healthy people.

2021-03-09 | GSE151963 | GEO

Microbiome in stool vs swabs in healthy people

Project description:Microbiome in stool vs swabs in healthy people

| PRJEB50814 | ENA

Altered gene expression in plasma of patients with pneumonia-induced sepsis compared to pneumonia without sepsis and healthy people

Project description:To investigate the differentially expressed genes in the plasma of pneumonia-induced sepsis patients compared to pneumonia patients without sepsis and healthy people, we performed gene expression profiling analysis using data obtained from RNA-seq.

2022-11-30 | GSE218494 | GEO

Fecal metatranscriptomics from healthy adults before and after supplementation with bovine milk oligosaccharides

Project description:Complex oligosaccharides found in human milk play a vital role in gut microbiome development for the human infant. Bovine milk oligosaccharides (BMO) have similar structures with those derived from human milk, but have not been well studied for their effects on the healthy adult human gut microbiome. Healthy human subjects consumed BMO over two-week periods at two different doses and provided fecal samples. Metatranscriptomics of fecal samples was conducted to determine microbial and host gene expression in response to the supplement. Fecal samples were also analyzed by mass spectrometry to determine levels of undigested BMO. No changes were observed in microbiome activity across all participants. Repeated sampling enabled subject-specific analyses: four of six participants had minor, yet statistically significant, changes in microbial activity. No significant change was observed in the gene expression of host cells in stool. Levels of BMO excreted in feces after supplementation were not significantly different from placebo and were not correlated with dosage or expressed microbial enzyme levels. Collectively, these data suggest that BMO is fully digested in the human gastrointestinal tract prior to stool collection. Participants’ gut microbiomes remained stable but varied between individuals. Additionally, the unaltered host transcriptome provides further evidence for the safety of BMO as a dietary supplement or food ingredient.

2020-02-18 | GSE108809 | GEO

Hepatic lipopolysaccharide binding protein uncouples inflammation from fibrosis in MAFLD

Project description:MAFLD is a heterogenous spectrum disorder affecting 20% of the population. Inflammatory processes contribute to various stages of MAFLD and thought to instigate hepatic fibrosis. For this reason, targeting inflammation has been heavily nominated as an approach to mitigating liver fibrosis. Lipopolysaccharide binding protein is a secreted protein that plays an established role in innate immune responses. In a murine model of MAFLD, we used a liver-specific deletion of LBP model to study its role in hepatic inflammation. Single nucleus RNA-seq were applied to investigate the role of LBP in hepatic cell composition.

2024-07-15 | GSE254626 | GEO

16S sequencing in patients with abnormal glucose tolerance and healthy people

Project description:16S sequencing in patients with abnormal glucose tolerance and healthy people Raw sequence reads

| PRJNA1019485 | ENA

fecal sample of cirrhotic patients and healthy individuals

Project description:fecal sample of cirrhotic patients and healthy individuals Raw sequence reads

| PRJNA976251 | ENA